[1] LIN G, QI K, LIU B, et al. A nomogram prognostic model for large cell lung cancer:analysis from the Surveillance, Epidemiology and End Results Database[J]. Transl Lung Cancer Res, 2021, 10(2):622-635. [2] ASAMURA H, KAMEYA T, MATSUNO Y, et al. Neuroendocrine neoplasms of the lung:a prognostic spectrum[J]. J Clin Oncol, 2006, 24(1):70-76. [3] GOLLARD R, JHATAKIA S, ELLIOTT M, et al. Large cell/neuroendocrine carcinoma[J]. Lung Cancer, 2010, 69(1):13-18. [4] GIATROMANOLAKI A, KOUKOURAKIS M I, SIVRIDIS E, et al. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival[J]. Br J Cancer, 2001, 85(6):881-890. [5] MASON D Y, BIBERFELD P. Technical aspects of lymphoma immunohistology[J]. J Histochem Cytochem, 1980, 28(8):731-745. [6] OHNO S, TERADA N, FUJII Y, et al. Dynamic structure of glomerular capillary loop as revealed by an in vivo cryotechnique[J]. Vichows Archiv A Pathol Anat, 1996, 427(5):519-527. [7] BAI Y Q, OHNO N, TERADA N, et al. Immunolocalization of serum proteins in xenografted mouse model of human tumor cells by various cryotechniques[J]. HistolHistopathol, 2009, 24(6):717-728. [8] OHNO N, TERADA N, BAI Y Q, et al. Application of cryobiopsy to morphological and immunohistochemical analyses of xenografted human lung cancer tissues and functional blood vessels[J]. Cancer, 2008, 113(5):1068-1079. [9] BAI Y Q, OHNO N, TERADA N, et al. Differential distribution of blood-derived proteins in xenografted human adenocarcinoma tissues by in vivo cryotechnique and cryobiopsy[J]. Med Mol Morphol, 2011, 44(2):93-102. [10] NAKAMURA N, MIYAGI E, MURATA S I, et al. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues[J]. Mod Pathol, 2002, 15(10):1058-1067. [11] HWANG D H, SZETO D P, PERRY A S, et al. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma[J]. Arch Pathol Lab Med, 2014, 138(5):626-635. [12] RUBIN E, FARBER J L. Neoplasia[M]//WINTERS R, MURPHY MB, MONROE K. Pathology. 3rd ed. Lippincottand Raven, 1999:172. [13] ZHONG H, HANRAHAN C, POEL H, et al. Hypoxia-inducible factor 1α and 1β proteins share common signaling pathways in human prostate cancer cells[J]. Biochem Biophys Res Commun, 2001, 284(2):352-356. [14] LEKAS A, LAZARIS A C, DELIVELIOTIS C, et al. The expression of hypoxia-inducible factor-1alpha (HIF-1αlpha) and angiogenesis markers in hyperplastic and malignant prostate tissue[J]. Anticancer Res, 2006, 26(4B):2989-2993. [15] HUANG M, DU H X, ZHANG L, et al. The association of HIF-1α expression with clinicopathological significance in prostate cancer:a meta-analysis[J]. Cancer Manag Res, 2018, 10:2809-2816. [16] NIE C Y, LV H F, BIE L Y, et al. Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer[J]. Medicine, 2018, 97(51):e13551. [17] BHASKAR A, TIWARY B N. Hypoxia inducible factor-1 alpha and multiple myeloma[J]. Int J Adv Res, 2016, 4(1):706-715. [18] KUMAR V, GABRILOVICH D I. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment[J]. Immunology, 2014, 143(4):512-519. [19] 白玉勤, 吴宝, 张龙, 等. 非小细胞肺癌移植瘤侵袭组织中血清蛋白的分布[J]. 癌变·畸变·突变, 2018, 30(2):132-135, 139. [20] 王徽, 白玉勤. 肺腺癌移植瘤裸鼠模型侵袭组织中酪氨酸蛋白激酶受体A7、表皮生长因子受体和Ki67蛋白表达及意义[J]. 陕西医学杂志, 2021, 50(9):1060-1063. [21] GAYED B A, O'MALLEY K J, PILCH J, et al. Digoxin inhibits blood vessel density and HIF-1α expression in castration-resistant C4-2 xenograft prostate tumors[J]. Clin Transl Sci, 2012, 5(1):39-42. [22] SHI L Y, TERADA N, SAITOH Y, et al. Immunohistochemical distribution of serum proteins in living mouse heart with In vivo cryotechnique[J]. Acta Histochem Cytochem, 2011, 44(2):61-72. |